Last reviewed · How we verify

NCT04397887

Seminal TEX101 as a Predictor of Recovery of Spermatogenesis in Azoospermic Men With Palpable Varicocele

Completed NA Last updated 21 May 2020
What this trial tests

NA trial testing micro-surgical varicocelectomy in Azoospermia, Nonobstructive in 40 participants. Completed in 30 April 2020.

Timeline
1 January 2019
Primary endpoint
30 April 2020
30 April 2020

Quick facts

Lead sponsorCairo University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment40
Start date1 January 2019
Primary completion30 April 2020
Estimated completion30 April 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 18 to 50, male only, with Azoospermia, Nonobstructive or Varicocele. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess if seminal TEX 101 can predict the restoration of spermatogenesis and appearance of sperms in the ejaculate after micro-surgical varicocelectomy among azoospermic patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Azoospermia, Nonobstructive

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04397887.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing